Cabot Corporation (NYSE:CBT) Receives Consensus Recommendation of “Hold” from Analysts

Cabot Corporation (NYSE:CBT) has been assigned an average rating of “Hold” from the seven brokerages that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and two have assigned a buy rating to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $85.80.

Several equities analysts have recently issued reports on the company. Wall Street Zen raised Cabot from a “hold” rating to a “buy” rating in a research note on Sunday, June 14th. JPMorgan Chase & Co. upped their price target on Cabot from $68.00 to $70.00 and gave the company an “underweight” rating in a research note on Wednesday, May 13th. Mizuho upped their price target on Cabot from $80.00 to $90.00 and gave the company a “neutral” rating in a research note on Thursday, June 25th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cabot in a research note on Tuesday, May 26th. Finally, UBS Group upped their price target on Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a research note on Friday, May 8th.

Cabot Price Performance

Cabot stock opened at $90.72 on Wednesday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.96 and a current ratio of 1.45. The firm has a market cap of $4.68 billion, a P/E ratio of 17.15, a P/E/G ratio of 11.88 and a beta of 0.82. The business’s fifty day moving average is $83.87 and its two-hundred day moving average is $76.14. Cabot has a 52 week low of $58.33 and a 52 week high of $94.53.

Cabot (NYSE:CBT) last posted its quarterly earnings data on Tuesday, May 5th. The specialty chemicals company reported $1.61 EPS for the quarter, topping analysts’ consensus estimates of $1.47 by $0.14. Cabot had a return on equity of 21.33% and a net margin of 7.97%.The company had revenue of $904.00 million for the quarter, compared to analyst estimates of $900.31 million. During the same quarter in the previous year, the firm earned $1.90 earnings per share. The business’s revenue was down 3.4% on a year-over-year basis. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. Equities research analysts forecast that Cabot will post 6.34 earnings per share for the current fiscal year.

Cabot Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, June 12th. Investors of record on Friday, May 29th were issued a $0.4725 dividend. This is a boost from Cabot’s previous quarterly dividend of $0.45. This represents a $1.89 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date was Friday, May 29th. Cabot’s dividend payout ratio is currently 35.73%.

Institutional Investors Weigh In On Cabot

A number of institutional investors and hedge funds have recently added to or reduced their stakes in CBT. Norges Bank bought a new stake in Cabot in the fourth quarter valued at about $49,662,000. AQR Capital Management LLC increased its holdings in Cabot by 123.0% in the second quarter. AQR Capital Management LLC now owns 867,946 shares of the specialty chemicals company’s stock valued at $65,096,000 after purchasing an additional 478,702 shares during the last quarter. UBS Group AG increased its holdings in Cabot by 186.7% in the third quarter. UBS Group AG now owns 593,510 shares of the specialty chemicals company’s stock valued at $45,136,000 after purchasing an additional 386,514 shares during the last quarter. Pacer Advisors Inc. increased its holdings in Cabot by 3,165.7% in the fourth quarter. Pacer Advisors Inc. now owns 229,252 shares of the specialty chemicals company’s stock valued at $15,195,000 after purchasing an additional 222,232 shares during the last quarter. Finally, American Century Companies Inc. increased its holdings in Cabot by 8.4% in the third quarter. American Century Companies Inc. now owns 1,805,393 shares of the specialty chemicals company’s stock valued at $137,300,000 after purchasing an additional 140,665 shares during the last quarter. Institutional investors own 93.18% of the company’s stock.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.